Revenue | ₹14,315.86Cr |
Net Profits | ₹2,278.63Cr |
Net Profit Margins | 15.92% |
Sun Pharmaceutical Industries Ltd’s revenue jumped 8.57% since last year same period to ₹14,315.86Cr in the Q1 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 5.48% jump in its revenue since last 3-months.
Sun Pharmaceutical Industries Ltd’s net profit fell -19.64% since last year same period to ₹2,278.63Cr in the Q1 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 5.99% jump in its net profits since last 3-months.
Sun Pharmaceutical Industries Ltd’s net profit margin fell -25.99% since last year same period to 15.92% in the Q1 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 0.48% jumped in its net profit margins since last 3-months.
The revenue for Sun Pharmaceutical Industries Ltd in the Q1 results 2025 was ₹14,315.86Cr.
The net profit for Sun Pharmaceutical Industries Ltd in the Q1 results 2025 was ₹2,278.63Cr.
The net profit margin for Sun Pharmaceutical Industries Ltd in the Q1 results 2025 was 15.92%.
The revenue for Sun Pharmaceutical Industries Ltd in the Q1 results 2024 was ₹13,185.30Cr.
The net profit for Sun Pharmaceutical Industries Ltd in the Q1 results 2024 was ₹2,835.62Cr.
The net profit margin for Sun Pharmaceutical Industries Ltd in the Q1 results 2024 was 21.51%.